Eudaimonia Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,151
| Closed | -$213K | – | 256 |
|
|
2023
Q3 | $213K | Sell |
3,151
-28
| -0.9% | -$1.9K | 0.05% | 294 |
|
|
2023
Q2 | $228K | Sell |
3,179
-338
| -10% | -$24.2K | 0.05% | 298 |
|
|
2023
Q1 | $244K | Buy |
3,517
+231
| +7% | +$16K | 0.06% | 286 |
|
|
2022
Q4 | $223K | Buy |
+3,286
| New | +$223K | 0.05% | 304 |
|
|
2022
Q3 | – | Sell |
-14,835
| Closed | -$980K | – | 344 |
|
|
2022
Q2 | $980K | Buy |
14,835
+1,328
| +10% | +$87.7K | 0.18% | 135 |
|
|
2022
Q1 | $896K | Buy |
+13,507
| New | +$896K | 0.15% | 164 |
|
|
2021
Q3 | $867K | Buy |
14,437
+940
| +7% | +$56.5K | 0.16% | 161 |
|
|
2021
Q2 | $808K | Sell |
13,497
-1,176
| -8% | -$70.4K | 0.15% | 165 |
|
|
2021
Q1 | $729K | Sell |
14,673
-307
| -2% | -$15.3K | 0.15% | 154 |
|
|
2020
Q4 | $749K | Buy |
14,980
+955
| +7% | +$47.8K | 0.17% | 140 |
|
|
2020
Q3 | $769K | Buy |
14,025
+4,840
| +53% | +$265K | 0.2% | 121 |
|
|
2020
Q2 | $486K | Buy |
9,185
+1,311
| +17% | +$69.4K | 0.18% | 129 |
|
|
2020
Q1 | $352K | Buy |
7,874
+5,000
| +174% | +$224K | 0.15% | 157 |
|
|
2019
Q4 | $143K | Buy |
+2,874
| New | +$143K | 0.06% | 291 |
|